Zobrazeno 1 - 10
of 14
pro vyhledávání: '"C T, Satheesh"'
Autor:
Kothari, Rushabh, Doshi, Maulik, Chaithanya, R. K., C. T., Satheesh, Kumar, Anil, Mallavarapu, Krishna Mohan, Nagarkar, Rajnish, Mahobia, Vijay, Bhatt, Niraj, Priyadarshini, K. L., Gogia, Ajay, Maksud, Tanveer, Prasad, Saurabh, Velavan, K., L. K., Rajeev, S.S., Prakash, Talreja, Vikas, Kalra, Kaushal, Nemade, Bhushan, Dastidar, Aloke Ghosh
Publikováno v:
Clinical Breast Cancer; Oct2024, Vol. 24 Issue 7, p639-646, 8p
Autor:
Ankit Patel, Niraj Bhatt, S. S. Prakash, Ghanashyam Biswas, Rajnish Nagarkar, Bodhisatta Roy, Priyanka Samal, Narendra Agrawal, Sushil Meshram, Ashish Kaushal, C. T. Satheesh, Ravikumar Wategaonkar, Kasi Viswanathan Thiagarajan, Kartikeya Jain, P. Vijayaveeran, Kalyan Mukherjee, Kishore Singh, Tushar Patil, Amit Jain, Tuphan Kanti Dolai, Minish Jain, Sachin Hingmire, Tara Chand Gupta, K. C. Lakshmaiah, Deepan Rajamanickam, Bhushan Nemade, Vikash Goyal, Pinaki Mahato, Sanjeev Kumar Mendiratta, Maulik Doshi
Publikováno v:
Cancer Chemotherapy and Pharmacology. 91:457-468
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82111331e29b226ab6f686b59eecd3bd
https://doi.org/10.1007/s00280-023-04530-x
https://doi.org/10.1007/s00280-023-04530-x
Autor:
Tejinder Singh, C S Premalata, K V Sajeevan, Ankit Jain, Ullas Batra, K S Saini, C T Satheesh, K Govind Babu, D Lokanatha
Publikováno v:
Journal of Laboratory Physicians, Vol 1, Iss 01, Pp 019-021 (2009)
Plasma cell leukemia (PCL) is a rare entity. There are two presentations of PCL, primary or secondary. The primary or de novo form of PCL presents with an acute and rapidly progressive leukemic phase. This form occurs when the patient has no pre-exis
Externí odkaz:
https://doaj.org/article/f202606033d9475b8eb2cc87e9dffed8
Autor:
Nalini Rao, Upasana Mukherjee, Sheela Ml, Mithua Ghosh, Basavalinga S. Ajaikumar, B Mahesh, Vaijayanti Gupta, Radheshyam Naik, U. Ashraf Mannan, Manjima Chatterjee, C T Satheesh, S. Patil, K. Murugan, Satish Sankaran
Publikováno v:
International Journal of Human Genetics. 16:120-127
Male breast carcinoma (MBC) is a rare cancer type that accounts 1 percent of the total breast cancer cases. This substantially invites diagnosis challenges and social burdens where the individual n...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e597adc08d6130565dea1e0bfbffd503
https://doi.org/10.1080/09723757.2016.11886287
https://doi.org/10.1080/09723757.2016.11886287
Autor:
Doddihal, Harsha, Marron, Thomas, C T, Satheesh, Avaronnan, Manuprasad, Nagarkar, Rajnish, Gupta, Vineet Govinda, Benjamin, Biju, Gowda, Nagaraj, Udupa, Venkatesha, Biswas, Nilanjana, Kadam, Jatin, Dhage, Priyanka, Beltran, Adam, Amin, Nikhil
Publikováno v:
HemaSphere; 2023 Supplement 3, Vol. 7, p1-2, 2p
Autor:
BS Kumar, H P Shashidhara, Rao, A Gangoli, Shivanand Patil, Ravi B Diwakar, Shilpa Prabhudesai, C T Satheesh, J Dixit, Diganta Hazarika, R Tejaswi, S Kakara, Vidya H Veldore, N Krishnamoorthy, KS Gopinath, Shamir Rahman, Radheshyam Naik, Subhrendu K. Pattanayak, Tejaswini Bn
Publikováno v:
Indian journal of cancer. 51(4)
Background: One of the genetic alterations implicated in tumor progression in colorectal cancers (CRCs) are abnormalities in Kristen Rat Sarcoma (KRAS) gene. Evaluation of KRAS mutation status is an important prognostic factor and has predictive valu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fae63a2dc0a9faf46cefce1fa3fa83b
https://pubmed.ncbi.nlm.nih.gov/26842186
https://pubmed.ncbi.nlm.nih.gov/26842186
Autor:
H P Shashidhara, Radheshyam Naik, Diganta Hazarika, Raghavendra M Rao, Ankita Prabhudev, Shilpa Prabhudesai, C T Satheesh, Naveen Krishnamoorthy, R Tejaswi, S. Patil, Vidya H Veldore, B S Ajai Kumar
Publikováno v:
Molecular diagnosistherapy. 20(2)
Although biopsy is the gold standard for diagnosis, cytological material has often been used to assist in making a pathologic diagnosis as well as for molecular testing in certain cancers such as in the lung, cervix, and head/neck.Our objective is to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7f76f1e31e6b6628739bc9655a302a9
https://pubmed.ncbi.nlm.nih.gov/26740090
https://pubmed.ncbi.nlm.nih.gov/26740090
Autor:
Shoukath M. Ali, Chen P, Hanmant Barkate, R.R. Patel, Moghis U. Ahmad, Makadia Rd, K U Choudhury, Imran Ahmad, Akash Kumar, Saifuddin Sheikh, Velavan K, Dipak Saptarishi, Prashant Kale, Mamillapalli G, Mahesh Paithankar, Singh Jk, Ateeq Ahmad, C T. Satheesh
Publikováno v:
Journal of Nanomedicine & Nanotechnology.
Objective:To develop Pegylated Doxorubicin Hydrochloride Liposome (PEGADRIA) and compare its physicochemical properties, preclinical safety and efficacy, clinical pharmacokinetic and safety profiles with those of the reference product, Doxil®. Metho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ade6e156c4a71e550be5bcd9fbae72f
https://doi.org/10.4172/2157-7439.1000361
https://doi.org/10.4172/2157-7439.1000361
Autor:
Satish Sankaran, Kalyanasundaram Subramanian, C T Satheesh, Urvashi Bahadur, N Krishnamoorthy, PS Sridhar, Basavalinga S. Ajaikumar, S Choudhury, H.P. Shashidhara, Mithua Ghosh, Radheshyam Nayak, Vaijayanti Gupta, B Mahesh, Nalini Rao, Suchitra S. Patil, K. Murugan, Sheela Ml
Publikováno v:
Cancer Research. 76:P6-07
Background: Numerous chemotherapeutic agents are available against breast cancer (BC), but a vast majority of patients diagnosed with this disease still develop treatment resistance and eventually succumb to disease. It remains an unmet need to ident
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6ff1d388d8c0c8b979fe4a0066a82bb
https://doi.org/10.1158/1538-7445.sabcs15-p6-07-01
https://doi.org/10.1158/1538-7445.sabcs15-p6-07-01
Autor:
ini, Shekhar Patil, Raghavendra Rao M, Malur R. Usharani, Naik Radheshyam, Diwakar B Ravi, Mahesh Kavya, Pkl N, H P Shashidhara, B.S. Ramesh, Kodaganur S. Gopinath, S Aishvarrya, C T Satheesh, Basavalinga S. Ajaikumar
Publikováno v:
Journal of Integrative Oncology.
Objective: Nausea and emesis are two major side effects and known to be partly psychological rather than purely pharmacological in nature. Yoga as a complimentary modality is extensively known to reduce anxiety, physiological arousal and stress assoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e6c57113c84b45b4852359517f58333
https://doi.org/10.4172/2329-6771.1000116
https://doi.org/10.4172/2329-6771.1000116